Acorda Therapeutics, Inc. Convertible Debt, Noncurrent
Acorda Therapeutics, Inc. had Convertible Debt, Noncurrent of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2024-04-01
- 2023-12-31: Convertible Debt, Noncurrent $0.00.
- 2023-09-30: Convertible Debt, Noncurrent $181.04M.
- 2023-06-30: Convertible Debt, Noncurrent $176.16M.
- 2023-03-31: Convertible Debt, Noncurrent $171.50M.
| Period end | Convertible Debt, Noncurrent | Convertible Debt, Noncurrent as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 | |
| 2023-09-30 | $181.04M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $176.16M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $171.50M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $167.03M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $162.76M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $158.67M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $154.76M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $151.03M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $147.45M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $144.03M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $140.75M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $137.62M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $134.62M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $131.76M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $195.35M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $192.77M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $326.38M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $323.78M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $321.21M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $318.67M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $316.16M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $313.68M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $311.23M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $308.81M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $306.41M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $304.05M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $301.71M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $299.39M 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | $297.11M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $294.85M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $292.62M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $290.42M 10-K · filed 2017-02-27 | $295.47M 10-K · filed 2016-02-29 |
| 2015-09-30 | $293.49M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $291.54M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $289.61M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $287.70M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $285.82M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $283.95M 10-Q · filed 2014-08-07 |